Le cannabis médicinal va  devenir un   médicament comme   un autre en Allemagne

Actualités

Le cannabis médicinal va devenir un médicament comme un autre en Allemagne

22 janvier 2016

Basé sur le projet de loi “cannabis médicinal”, le cannabis pourrait devenir prescriptible comme toute autre substance contrôlée à usage médical. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

By Mariana Pinzon

The german government has finally published the draft for the new bill “Cannabis as medicine” on the website of the Federal Ministry of Health on January 7th.

After much speculation on the details of the bill in the last couple of months, now the draft for the law is public. Allthough there still might be some changes in the process of implementing the law, it looks quite positive. Here are the main cornerstones:

- There will be no further need for exemption licences to use legal medical cannabis.

- Any Doctor will be able to prescribe Cannabis flowers for patients on a special receipt, just like any other prescription drug available in german pharmacies.

- In addition, the costs for the flowers will"in certain cases" be covered by the regular health insurance.

- In order to secure the supply for german patients a cannabis agency will be established. The cannabis agency will issue licenses for commercial cultivation of cannabis and distribute it to the regular pharmacies.

If the draft bill passes into law, cannabis flowers will be prescribable as a controlled substance with medical use and listed in Schedule III of the german Narcotics Act (BtMG). It will be deleted from Schedule I and II, which list the narcotics that are non-prescribable and those controlled substances which are not marketable. With these changes patients will not need any special permits to use the narcotic prescription. Any doctor will be able to hand out these prescriptions.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: Wikipedia